Table of Contents

Reviews

• You have access

  Genetically Engineered Insulin Analogs: Diabetes in the New Millenium

  Zoltan Vajo and William C. Duckworth

  Pharmacological Reviews March 2000, 52 (1) 1-10;
• You have access

  Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases

  Shokei Kim and Hiroshi Iwao

  Pharmacological Reviews March 2000, 52 (1) 11-34;
• You have access

  Transgenic Approach to the Study of Body Weight Regulation

  Akio Inui

  Pharmacological Reviews March 2000, 52 (1) 35-62;
• You have access

  Role of High-Affinity Receptors and Membrane Transporters in Nonsynaptic Communication and Drug Action in the Central Nervous System

  E. Sylvester Vizi

  Pharmacological Reviews March 2000, 52 (1) 63-90;
• You have access

  C1-Esterase Inhibitor: An Anti-Inflammatory Agent and Its Potential Use in the Treatment of Diseases Other Than Hereditary Angioedema

  C. Caliezi, W. A. Wuillemin, S. Zeerleder, M. Redondo, B. Eisele and C. E. Hack

  Pharmacological Reviews March 2000, 52 (1) 91-112;
• You have access

  Molecular Interactions with Mercury in the Kidney

  Rudolfs K. Zalups

  Pharmacological Reviews March 2000, 52 (1) 113-144;
• You have access

  International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors

  Philip M. Murphy, Marco Baggiolini, Israel F. Charo, Caroline A. Hébert, Richard Horuk, Kouji Matsushima, Louis H. Miller, Joost J. Oppenheim and Christine A. Power

  Pharmacological Reviews March 2000, 52 (1) 145-176;